Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $32.3 million.

  • Nuvation Bio's Non-cash Items rose 3884.11% to $32.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.3 million, marking a year-over-year increase of 3884.11%. This contributed to the annual value of $24.2 million for FY2024, which is 15872.51% up from last year.
  • Per Nuvation Bio's latest filing, its Non-cash Items stood at $32.3 million for Q3 2025, which was up 3884.11% from $29.6 million recorded in Q2 2025.
  • Nuvation Bio's Non-cash Items' 5-year high stood at $32.3 million during Q3 2025, with a 5-year trough of $3.1 million in Q1 2023.
  • For the 3-year period, Nuvation Bio's Non-cash Items averaged around $18.2 million, with its median value being $23.3 million (2024).
  • As far as peak fluctuations go, Nuvation Bio's Non-cash Items skyrocketed by 28788.17% in 2024, and later soared by 2359.52% in 2025.
  • Quarter analysis of 3 years shows Nuvation Bio's Non-cash Items stood at $9.4 million in 2023, then skyrocketed by 158.73% to $24.2 million in 2024, then skyrocketed by 33.21% to $32.3 million in 2025.
  • Its Non-cash Items was $32.3 million in Q3 2025, compared to $29.6 million in Q2 2025 and $27.0 million in Q1 2025.